Sanofi (SNY) is mulling an acquisition of US drugmaker Insmed (INSM), Bloomberg reported Thursday, citing people familiar with the matter.
Sanofi is in talks with advisers as it evaluates a potential deal for Insmed, the shares of which have dropped about 40% over the last year, giving it a market value of about $26.6 billion, the report said, citing the people.
Deliberations are underway and any deal could still be weeks away, the report said, citing the people.
Sanofi and Insmed didn't immediately reply to requests for comment from MT Newswires.
(Market Chatter news is derived from conversations with market professionals globally. This information is believed to be from reliable sources but may include rumor and speculation. Accuracy is not guaranteed.)
Price: 45.46, Change: -1.67, Percent Change: -3.53
Comments